300109 Stock Overview
Engages in the fine chemical and medical care businesses in China and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
My Notes
Capture your thoughts, links and company narrative
Boai NKY Medical Holdings Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥16.81 |
| 52 Week High | CN¥18.98 |
| 52 Week Low | CN¥8.02 |
| Beta | 0.12 |
| 1 Month Change | 15.06% |
| 3 Month Change | 71.18% |
| 1 Year Change | 44.75% |
| 3 Year Change | 12.02% |
| 5 Year Change | 55.07% |
| Change since IPO | 59.53% |
Recent News & Updates
Further Upside For Boai NKY Medical Holdings Ltd. (SZSE:300109) Shares Could Introduce Price Risks After 28% Bounce
Dec 09
We Think That There Are More Issues For Boai NKY Medical Holdings (SZSE:300109) Than Just Sluggish Earnings
Oct 31Recent updates
Further Upside For Boai NKY Medical Holdings Ltd. (SZSE:300109) Shares Could Introduce Price Risks After 28% Bounce
Dec 09We Think That There Are More Issues For Boai NKY Medical Holdings (SZSE:300109) Than Just Sluggish Earnings
Oct 31Market Might Still Lack Some Conviction On Boai NKY Medical Holdings Ltd. (SZSE:300109) Even After 40% Share Price Boost
Oct 08Boai NKY Medical Holdings Ltd. (SZSE:300109) Doing What It Can To Lift Shares
Aug 23Does Boai NKY Medical Holdings (SZSE:300109) Have A Healthy Balance Sheet?
Jul 25Boai NKY Medical Holdings (SZSE:300109) Is Paying Out A Larger Dividend Than Last Year
Jun 04We Like These Underlying Return On Capital Trends At Boai NKY Medical Holdings (SZSE:300109)
May 27Should You Be Adding Boai NKY Medical Holdings (SZSE:300109) To Your Watchlist Today?
Apr 03Boai NKY Medical Holdings Ltd. (SZSE:300109) Stock Rockets 39% But Many Are Still Ignoring The Company
Mar 04Shareholder Returns
| 300109 | CN Chemicals | CN Market | |
|---|---|---|---|
| 7D | 0.7% | -2.3% | -1.2% |
| 1Y | 44.7% | 0.7% | 11.8% |
Return vs Industry: 300109 exceeded the CN Chemicals industry which returned 0.7% over the past year.
Return vs Market: 300109 exceeded the CN Market which returned 11.8% over the past year.
Price Volatility
| 300109 volatility | |
|---|---|
| 300109 Average Weekly Movement | 11.1% |
| Chemicals Industry Average Movement | 8.2% |
| Market Average Movement | 8.7% |
| 10% most volatile stocks in CN Market | 12.8% |
| 10% least volatile stocks in CN Market | 5.7% |
Stable Share Price: 300109's share price has been volatile over the past 3 months compared to the CN market.
Volatility Over Time: 300109's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of CN stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1987 | 1,165 | Junzheng Zhang | www.boai-nky.com |
Boai NKY Medical Holdings Ltd. engages in the fine chemical and medical care businesses in China and internationally. The company offers polyvinylpyrrolidone (PVP) series products, and vinyl methyl ether and maleic acid products; anhydride copolymer (PVME/MA) series products; GBL, 2-pyrrolidone, NVP monomer, PVPK series (povidone), copovidone, and other VP/VA copolymer series products; and PVPP (cross-linked povidone), PVP-I, and related pharmaceutical intermediates.
Boai NKY Medical Holdings Ltd. Fundamentals Summary
| 300109 fundamental statistics | |
|---|---|
| Market cap | CN¥8.15b |
| Earnings (TTM) | CN¥399.35m |
| Revenue (TTM) | CN¥1.49b |
20.4x
P/E Ratio5.5x
P/S RatioIs 300109 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 300109 income statement (TTM) | |
|---|---|
| Revenue | CN¥1.49b |
| Cost of Revenue | CN¥737.63m |
| Gross Profit | CN¥750.25m |
| Other Expenses | CN¥350.90m |
| Earnings | CN¥399.35m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.82 |
| Gross Margin | 50.42% |
| Net Profit Margin | 26.84% |
| Debt/Equity Ratio | 11.6% |
How did 300109 perform over the long term?
See historical performance and comparisonDividends
4.0%
Current Dividend Yield77%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 05:50 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Boai NKY Medical Holdings Ltd. is covered by 4 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jun Liu | Changjiang Securities Co. LTD. |
| Zheng Zhou | China Merchants Securities Co. Ltd. |
| Zhenghua Zhang | Founder Securities Co., Ltd. |